Moxibustion Societies (WFAS) released an evidence-based, patient-centred clinical practice guideline on acupuncture and moxibustion for non-specific low back pain to populations in many countries and ...
The first comprehensive guidelines dedicated to minimizing infections in patients undergoing surgeries and procedures ...
Back pain is among the most common forms of pain patients endure, and can severely alter their quality of life and ability to ...
Despite routine prescription, opioids are not recommended for initial intervention by any major multidisciplinary low back pain (LBP) guideline. Objective Our ... interventions prescribed for ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The drug exhibits anti-inflammatory and analgesic activity in various experimental models for acute and chronic painful ... for diclofenac potassium. Low back pain was selected as a pain model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results